This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Sponsors May Not Smile for Shutterfly's Price: Chart of the Day

Tech sector LBOs are hot this fall, and in September, we've seen a number of big auctions generate big returns for investors.

Walgreen Aims to Invert Earnings, Harley Sales Stall, Cramer's AIG Pick

Walgreen is one of Jim Cramer's many Action Alert Picks, but this morning, the U.S. retailer that is staying in the U.S. announces earnings.

What to Watch on Wall Street for Tuesday, September 30th

Here's "What to Watch on Wall Street" for Tuesday, September 30th.

BMW Launches Automated Driving Project in China with Baidu

BMW is testing out self-driving cars in China.

Cintas Beats Q1 Street Estimates, Offers Bullish Outlook

Cintas posted first quarter earnings of $0.93 a share on revenue of $1.10 billion.

Real Money Previews

Kass: Why Now Is a Good Time to Be an Investor in Yahoo!

The sum-of-the-parts analysis yields a far richer share price vs. current levels.

Jim Cramer on the Stock Market: What Nike Is Telling Us

Maybe its stellar result shows things aren't that bad.

Top 10 Reasons for Being Cautious; An Oldie But Goodie: Best of Kass

In highlights from his trading diary of the past week, Doug Kass writes about caution in the market and words of wisdom from 'Fast Times at Ridgemont High.'

Mad Money Recap

'Mad Money' Lightning Round: I'm Not Very Happy With Oracle

Cramer is no fan of Annaly Capital but does like Opko Health and Dow Chemical.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

3 Big Stocks on Traders' Radars

Here's how to trade some of the most active stocks on the market.

How to Trade the Market's Most-Active Stocks: JNS, PBR, TIBX, ATHL

Here's a look at how to trade some of the most active stocks on the market today.

3 Unusual-Volume Stocks Triggering Breakout Trades

Keep these stokcs rising on unusual volume on your breakout trading radar.

Forget the Top Talk -- QE5 Is Coming, and Here's How to Profit

The Fed is ready to step in and dump cash into the system again. Here's why -- and how to take advantage with your portfolio.

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

MainStreet

We'll Probably Never Fully Embrace Wearables Like The Apple Watch

Tech analysts says smartwatches, bracelets and glasses will boom over the next couple of years but warn that they will fade quickly if they don't find their niches.

Federal Student Loan Default Rates Sink -- Just Not Very Much

Federal student loan default rates are down for 2013. But Education Secretary Arne Duncan isn’t gloating.

10 Most Fuel-Efficient Diesel Vehicles You Can Buy In 2014

While German automakers have always seen the value in diesel efficiency, their American counterparts are starting to come around to its benefits.

Why Consumer Optimism Is Damning Your Chances of Buying a Home

As the economy continues to make modest improvements, consumer sentiment continues to rise. That means higher home prices.

What to Do When You Send an Email You Absolutely Shouldn’t Have

Did you accidentally type something in an email you wish you could take back? Here’s how to recover.

Biotech

Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug

For the zero work done by Catalyst, LEMS patients will pay as much as $80,000 for the exact same drug they use now for a fraction of the cost.

Clovis Shares Higher on Improved Outlook for Lung Cancer Drug

Clovis Oncology shares are higher Monday because AstraZeneca, its direct competitor to develop a new, genetically targeted lung cancer drug, slipped this weekend.

Seattle Genetics Seeks Expanded Use of Lymphoma Drug on Study Win

Adcetris delayed disease progression in Hodgkin lymphoma patients following a stem cell transplant.

Beyond Wall St.

Deal News

Sponsors May Not Smile for Shutterfly's Price: Chart of the Day

Tech sector LBOs are hot this fall, and in September, we've seen a number of big auctions generate big returns for investors.

DreamWorks and SoftBank Deal Talks Reportedly Have Cooled

Deal talks between DreamWorks and SoftBank have reportedly cooled, leaving investors wondering if their hope for a blockbuster merger has now become a bust.

Yahoo's Marissa Mayer to Review Starboard's Proposed AOL Bid

The pressure is on Yahoo CEO Marissa Mayer to explore a tie-up with AOL.

TheStreetTV
Spin Space

Jim Cramer

Cramer Answers Twitter Questions on Yahoo!, Ciena, Bank of America

Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.

Herb Greenberg

Herb Greenberg: Too Soon to Question GoPro's Earnings Quality?

Keep these points from its most recent quarter in mind.

Stephanie Link

Jim Cramer Tells Stephanie Link Downtrend in Commodities an Opportunity to Buy

Recently commodities such as oil, gold and iron ore have been taking it on the chin with prices at their lowest level in five years.

Chris Ciaccia

Apple Gets Another Grand Entrance in China, iPhone 6 On Sale in October

Apple finally gets its big entry into China, as the company will be selling its iPhone and iPhone 6 Plus starting Oct. 17 into the world's largest cellular market.

Adam Feuerstein

Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug

For the zero work done by Catalyst, LEMS patients will pay as much as $80,000 for the exact same drug they use now for a fraction of the cost.

Dan Freed

Mortgage REITs Offer Great Yields, but Big Risks Remain

If the market moves sideways and interest rates stay lower for longer, mortgage REITS like Annaly and AGNC may be one of the few ways to outperform the market.

Ted Reed

Airbus A320neo Takes Its First Flight, Will Fly for American in 2017

American Airlines, which operates the world's largest Airbus fleet, has orders for 100 Airbus A320neos and expects its first aircraft in 2017.

Leon Lazaroff

Programmatic Ad-Buying Is Just Google Search Writ Large

Programmatic ad-buying is the new rage in the advertising world, but boiled down, it's Google Search for online video and display.

Submit an article to us!
DOW 17,047.66 -23.56 -0.14%
S&P 500 1,978.32 +0.52 0.03%
NASDAQ 4,510.2130 +4.3610 0.10%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs